Abstract
Fluopimomide, developed by Shandong Sino-Agri United Biotechnology Co., Ltd., is a pyridinylmethyl-benzamide fungicide with good activity against plant diseases caused by phytopathogenic oomycetes. However, there is uncertainty surrounding the resistance risk of fluopimomide and its resistance mechanism in Phytophthora capsici. In this study, the baseline sensitivity of P. capsici to fluopimomide was established, and 106 P. capsici isolates shown sensitive to fluopimomide, with a mean EC50 value of 5.1892 ± 2.2613 μg/mL. Fungicide adaptation produced three fluopimomide-resistant P. capsici mutants, two of which exhibited considerably lower compound fitness index (CFI) than the parent strain, and one showed significantly improved CFI. While cross-resistance was observed between fluopimomide and fluopicolide, no cross-resistance was detected between fluopimomide and other fungicides. Overall, P. capsici presents a moderate resistance risk to fluopimomide. Two point mutations, G767E and K847R, were identified in the V-ATPase subunit a of P. capsici (PcVHA-a) in resistant mutants. These mutations were subsequently validated through site-directed mutagenesis and molecular docking assays, confirming their role in conferring fluopimomide resistance in P. capsici.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
